 |
2.60.40.10.46.1.1.1.1 |
1my5A00 |
RIG-I-like receptor signaling pathway, liver development, Apoptosis, Toll-like receptor signaling pathway, Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide, positive regulation of interleukin-12 biosynthetic process, Chronic myeloid leukemia, Leishmaniasis, NOD-like receptor signaling pathway, Transcription factor p65, hair follicle development, Chemokine signaling pathway, Pancreatic cancer, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Neurotrophin signaling pathway, transcription activator activity, Mus musculus, transcription factor p65, Small cell lung cancer, Prostate cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Pathways in cancer, Acute myeloid leukemia, organ morphogenesis |
 |
 |
2.60.40.10.46.1.1.1.2 |
1my5B00 |
Leishmaniasis, NOD-like receptor signaling pathway, Chronic myeloid leukemia, positive regulation of interleukin-12 biosynthetic process, hair follicle development, Transcription factor p65, B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Adipocytokine signaling pathway, RIG-I-like receptor signaling pathway, Apoptosis, Toll-like receptor signaling pathway, liver development, Pathways in cancer, organ morphogenesis, Acute myeloid leukemia, Prostate cancer, Small cell lung cancer, MAPK signaling pathway, negative regulation of protein catabolic process, Neurotrophin signaling pathway, transcription factor p65, Mus musculus, transcription activator activity, Chemokine signaling pathway, Pancreatic cancer, Cytosolic DNA-sensing pathway, T cell receptor signaling pathway |
 |
 |
2.60.40.10.46.1.1.1.3 |
1bftA00 |
hair follicle development, Transcription factor p65, positive regulation of interleukin-12 biosynthetic process, Leishmaniasis, NOD-like receptor signaling pathway, Chronic myeloid leukemia, B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Adipocytokine signaling pathway, liver development, Toll-like receptor signaling pathway, Apoptosis, RIG-I-like receptor signaling pathway, Acute myeloid leukemia, organ morphogenesis, Pathways in cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Small cell lung cancer, Prostate cancer, transcription activator activity, transcription factor p65, Mus musculus, Neurotrophin signaling pathway, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Pancreatic cancer, Chemokine signaling pathway |
 |
 |
2.60.40.10.46.1.1.1.4 |
1bftB00 |
Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Apoptosis, liver development, NOD-like receptor signaling pathway, Leishmaniasis, Chronic myeloid leukemia, positive regulation of interleukin-12 biosynthetic process, Transcription factor p65, hair follicle development, B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide, Neurotrophin signaling pathway, Mus musculus, transcription factor p65, transcription activator activity, Chemokine signaling pathway, Pancreatic cancer, Cytosolic DNA-sensing pathway, T cell receptor signaling pathway, Pathways in cancer, organ morphogenesis, Acute myeloid leukemia, Prostate cancer, Small cell lung cancer, MAPK signaling pathway, negative regulation of protein catabolic process |
 |
 |
2.60.40.10.46.1.1.1.5 |
1oy3B00 |
Pathways in cancer, Acute myeloid leukemia, organ morphogenesis, Small cell lung cancer, Prostate cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Neurotrophin signaling pathway, transcription activator activity, Mus musculus, transcription factor p65, Chemokine signaling pathway, Pancreatic cancer, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, positive regulation of interleukin-12 biosynthetic process, Chronic myeloid leukemia, Leishmaniasis, NOD-like receptor signaling pathway, Transcription factor p65, hair follicle development, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide, Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, RIG-I-like receptor signaling pathway, liver development, Apoptosis, Toll-like receptor signaling pathway |
 |
 |
2.60.40.10.46.1.1.1.6 |
2ramA02 |
positive regulation of interleukin-12 biosynthetic process, Leishmaniasis, Chronic myeloid leukemia, NOD-like receptor signaling pathway, Transcription factor p65, hair follicle development, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide, Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, RIG-I-like receptor signaling pathway, liver development, Toll-like receptor signaling pathway, Apoptosis, Pathways in cancer, Acute myeloid leukemia, organ morphogenesis, Small cell lung cancer, Prostate cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Neurotrophin signaling pathway, transcription activator activity, Mus musculus, transcription factor p65, Chemokine signaling pathway, Pancreatic cancer, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway |
 |
 |
2.60.40.10.46.1.1.1.7 |
2ramB02 |
Transcription factor p65, hair follicle development, positive regulation of interleukin-12 biosynthetic process, NOD-like receptor signaling pathway, Chronic myeloid leukemia, Leishmaniasis, B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide, Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, liver development, Toll-like receptor signaling pathway, Apoptosis, RIG-I-like receptor signaling pathway, Acute myeloid leukemia, organ morphogenesis, Pathways in cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Small cell lung cancer, Prostate cancer, transcription activator activity, Mus musculus, transcription factor p65, Neurotrophin signaling pathway, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Pancreatic cancer, Chemokine signaling pathway |
 |
 |
2.60.40.10.46.1.1.1.8 |
1leiA02 |
transcription activator activity, transcription factor p65, Mus musculus, Neurotrophin signaling pathway, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Chemokine signaling pathway, Pancreatic cancer, Acute myeloid leukemia, organ morphogenesis, Pathways in cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Small cell lung cancer, Prostate cancer, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Adipocytokine signaling pathway, liver development, Toll-like receptor signaling pathway, Apoptosis, RIG-I-like receptor signaling pathway, hair follicle development, Transcription factor p65, positive regulation of interleukin-12 biosynthetic process, NOD-like receptor signaling pathway, Leishmaniasis, Chronic myeloid leukemia, B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide |
 |
 |
2.60.40.10.46.1.1.1.9 |
1ramA02 |
transcription activator activity, transcription factor p65, Mus musculus, Neurotrophin signaling pathway, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Chemokine signaling pathway, Pancreatic cancer, Acute myeloid leukemia, organ morphogenesis, Pathways in cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Small cell lung cancer, Prostate cancer, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Adipocytokine signaling pathway, liver development, Apoptosis, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, hair follicle development, Transcription factor p65, positive regulation of interleukin-12 biosynthetic process, Chronic myeloid leukemia, NOD-like receptor signaling pathway, Leishmaniasis, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide |
 |
 |
2.60.40.10.46.1.1.1.10 |
1ramB02 |
B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide, positive regulation of interleukin-12 biosynthetic process, Chronic myeloid leukemia, Leishmaniasis, NOD-like receptor signaling pathway, hair follicle development, Transcription factor p65, RIG-I-like receptor signaling pathway, liver development, Toll-like receptor signaling pathway, Apoptosis, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Adipocytokine signaling pathway, Small cell lung cancer, Prostate cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Pathways in cancer, Acute myeloid leukemia, organ morphogenesis, Pancreatic cancer, Chemokine signaling pathway, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Neurotrophin signaling pathway, transcription activator activity, transcription factor p65, Mus musculus |
 |
 |
2.60.40.10.46.1.1.1.11 |
1le5A02 |
B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide, Leishmaniasis, Chronic myeloid leukemia, NOD-like receptor signaling pathway, positive regulation of interleukin-12 biosynthetic process, Transcription factor p65, hair follicle development, RIG-I-like receptor signaling pathway, Apoptosis, Toll-like receptor signaling pathway, liver development, Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Prostate cancer, Small cell lung cancer, MAPK signaling pathway, negative regulation of protein catabolic process, Pathways in cancer, organ morphogenesis, Acute myeloid leukemia, Chemokine signaling pathway, Pancreatic cancer, Cytosolic DNA-sensing pathway, T cell receptor signaling pathway, Neurotrophin signaling pathway, Mus musculus, transcription factor p65, transcription activator activity |
 |
 |
2.60.40.10.46.1.1.1.12 |
1le5E02 |
Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Apoptosis, liver development, Chronic myeloid leukemia, Leishmaniasis, NOD-like receptor signaling pathway, positive regulation of interleukin-12 biosynthetic process, Transcription factor p65, hair follicle development, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide, Neurotrophin signaling pathway, Mus musculus, transcription factor p65, transcription activator activity, Chemokine signaling pathway, Pancreatic cancer, Cytosolic DNA-sensing pathway, T cell receptor signaling pathway, Pathways in cancer, organ morphogenesis, Acute myeloid leukemia, Prostate cancer, Small cell lung cancer, MAPK signaling pathway, negative regulation of protein catabolic process |
 |
 |
2.60.40.10.46.1.1.1.13 |
2i9tA02 |
transcription activator activity, transcription factor p65, Mus musculus, Neurotrophin signaling pathway, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Pancreatic cancer, Chemokine signaling pathway, Acute myeloid leukemia, organ morphogenesis, Pathways in cancer, negative regulation of protein catabolic process, MAPK signaling pathway, Small cell lung cancer, Prostate cancer, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Adipocytokine signaling pathway, liver development, Apoptosis, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, hair follicle development, Transcription factor p65, positive regulation of interleukin-12 biosynthetic process, Chronic myeloid leukemia, Leishmaniasis, NOD-like receptor signaling pathway, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide |
 |
 |
2.60.40.10.46.1.1.1.14 |
1vkxA02 |
negative regulation of protein catabolic process, MAPK signaling pathway, Small cell lung cancer, Prostate cancer, Acute myeloid leukemia, organ morphogenesis, Pathways in cancer, T cell receptor signaling pathway, Cytosolic DNA-sensing pathway, Chemokine signaling pathway, Pancreatic cancer, transcription activator activity, transcription factor p65, Mus musculus, Neurotrophin signaling pathway, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide, hair follicle development, Transcription factor p65, positive regulation of interleukin-12 biosynthetic process, Chronic myeloid leukemia, NOD-like receptor signaling pathway, Leishmaniasis, liver development, Toll-like receptor signaling pathway, Apoptosis, RIG-I-like receptor signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Adipocytokine signaling pathway |
 |
 |
2.60.40.10.46.1.1.1.15 |
1le9A02 |
Leishmaniasis, Chronic myeloid leukemia, NOD-like receptor signaling pathway, positive regulation of interleukin-12 biosynthetic process, Transcription factor p65, hair follicle development, B cell receptor signaling pathway, Chagas disease, response to muramyl dipeptide, Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Apoptosis, liver development, Pathways in cancer, organ morphogenesis, Acute myeloid leukemia, Prostate cancer, Small cell lung cancer, MAPK signaling pathway, negative regulation of protein catabolic process, Neurotrophin signaling pathway, Mus musculus, transcription factor p65, transcription activator activity, Pancreatic cancer, Chemokine signaling pathway, Cytosolic DNA-sensing pathway, T cell receptor signaling pathway |
 |
 |
2.60.40.10.46.1.1.1.16 |
1le9E02 |
Toll-like receptor signaling pathway, Apoptosis, liver development, RIG-I-like receptor signaling pathway, Adipocytokine signaling pathway, sequence-specific enhancer binding RNA polymerase II transcription factor activity, Chagas disease, B cell receptor signaling pathway, response to muramyl dipeptide, Transcription factor p65, hair follicle development, NOD-like receptor signaling pathway, Chronic myeloid leukemia, Leishmaniasis, positive regulation of interleukin-12 biosynthetic process, Cytosolic DNA-sensing pathway, T cell receptor signaling pathway, Chemokine signaling pathway, Pancreatic cancer, Mus musculus, transcription factor p65, transcription activator activity, Neurotrophin signaling pathway, MAPK signaling pathway, negative regulation of protein catabolic process, Prostate cancer, Small cell lung cancer, organ morphogenesis, Acute myeloid leukemia, Pathways in cancer |
 |